These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11996888)

  • 1. Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine.
    Salerno M; Przewloka T; Fokt I; Priebe W; Garnier-Suillerot A
    Biochem Pharmacol; 2002 Apr; 63(8):1471-9. PubMed ID: 11996888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.
    Frézard F; Pereira-Maia E; Quidu P; Priebe W; Garnier-Suillerot A
    Eur J Biochem; 2001 Mar; 268(6):1561-7. PubMed ID: 11248673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.
    Marbeuf-Gueye C; Ettori D; Priebe W; Kozlowski H; Garnier-Suillerot A
    Biochim Biophys Acta; 1999 Jul; 1450(3):374-84. PubMed ID: 10395948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin.
    Loetchutinat C; Heywang C; Priebe W; Garnier-Suillerot A
    Biochem Pharmacol; 2001 Sep; 62(5):561-7. PubMed ID: 11585053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
    Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
    Eur J Pharmacol; 2001 Feb; 413(2-3):131-41. PubMed ID: 11226386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
    Fu D; Roufogalis BD
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1543-52. PubMed ID: 17122416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance.
    Andrivon W; Monneret C; Nafziger J; Florent JC; Guillosson JJ
    Leuk Res; 1998 Aug; 22(8):719-25. PubMed ID: 9680099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.
    Seelig A; Blatter XL; Wohnsland F
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):111-21. PubMed ID: 10739114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
    Mülder HS; Dekker H; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein.
    Kondratov RV; Komarov PG; Becker Y; Ewenson A; Gudkov AV
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14078-83. PubMed ID: 11707575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):69-79. PubMed ID: 27810353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idarubicin DNA intercalation is reduced by MRP1 and not Pgp.
    Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Boezeman J; Minderman H; de Witte TM
    Leukemia; 1999 Sep; 13(9):1390-8. PubMed ID: 10482990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine.
    Tseng E; Kamath A; Morris ME
    Pharm Res; 2002 Oct; 19(10):1509-15. PubMed ID: 12425469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.